EU-funded projects

Developing a therapy that recruits the immune system to fight cancer and specifically targets the GARP-TGFβ1 complex
Development of the first in class therapeutic device for use in the treatment of autoimmune neurodegenerative disease
Developing a therapy that recruits the immune system to fight cancer and specifically targets integrin αVβ8
Development of the first-in-class therapeutic medical device indicated to use during myasthenic crisis in myasthenia gravis patients
Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers